Bicyclic amides as kinase inhibitors

Details for Australian Patent Application No. 2009201090 (hide)

Owner Novartis AG

Inventors Little-Wood-Evans, Amanda Jane; Pissot Soldermann, Carole; Bajwa, Joginder S.; Caravatti, Giorgio; Gessier, Francois; Manley, Paul W.; Furet, Pascal; Floersheimer, Andreas; Schnell, Christian; Kapa, Prasad Koteswara; Jiang, Xinglong; Capraro, Hans-georg; Bold, Guido; Vaupel, Andrea

Agent Davies Collison Cave

Pub. Number AU-B-2009201090

Parent 2005310968

Filing date 18 March 2009

Wipo publication date 9 April 2009

Acceptance publication date 15 March 2012

International Classifications

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 April 2009 Complete Application Filed

9 April 2009 Application Open to Public Inspection

  Published as AU-B-2009201090

15 March 2012 Application Accepted

  Published as AU-B-2009201090

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201091-Double-stranded ribonucleic acid with increased effectiveness in an organism

2009201089-Fire Sprinkler Systems, Hydrant Systems, Hydronic Systems and the Like